AMLX
Price:
$3.5575
Market Cap:
$242.20M
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2022-01-07
Stock Exchange
NASDAQ
Ticker
AMLX
According to Amylyx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.45. This represents a change of -108.74% compared to the average of 16.60 of the last 4 quarters.
The mean historical PE Ratio of Amylyx Pharmaceuticals, Inc. over the last ten years is -19.16. The current -1.45 PE Ratio has changed 656.59% with respect to the historical average. Over the past ten years (40 quarters), AMLX's PE Ratio was at its highest in in the March 2023 quarter at 311.11. The PE Ratio was at its lowest in in the December 2020 quarter at -24.16.
Average
-19.16
Median
-12.39
Minimum
-68.87
Maximum
20.09
Discovering the peaks and valleys of Amylyx Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.12%
Maximum Annual PE Ratio = 20.09
Minimum Annual Increase = -262.14%
Minimum Annual PE Ratio = -68.87
Year | PE Ratio | Change |
---|---|---|
2023 | 20.09 | -262.14% |
2022 | -12.39 | 4.12% |
2021 | -11.90 | -47.72% |
2020 | -22.76 | -66.96% |
The current PE Ratio of Amylyx Pharmaceuticals, Inc. (AMLX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.40
5-year avg
-19.16
10-year avg
-19.16
Amylyx Pharmaceuticals, Inc.’s PE Ratio is greater than Terns Pharmaceuticals, Inc. (-5.83), greater than Acumen Pharmaceuticals, Inc. (-2.15), greater than Inozyme Pharma, Inc. (-3.55), less than X4 Pharmaceuticals, Inc. (5.69), greater than Day One Biopharmaceuticals, Inc. (-7.18), greater than Mereo BioPharma Group plc (-17.84), greater than PDS Biotechnology Corporation (-3.08), less than HOOKIPA Pharma Inc. (-0.97),
Company | PE Ratio | Market cap |
---|---|---|
-5.83 | $634.11M | |
-2.15 | $139.44M | |
-3.55 | $318.06M | |
5.69 | $84.27M | |
-7.18 | $1.21B | |
-17.84 | $651.96M | |
-3.08 | $125.92M | |
-0.97 | $45.33M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amylyx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amylyx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Amylyx Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Amylyx Pharmaceuticals, Inc. (AMLX)?
What is the highest PE Ratio for Amylyx Pharmaceuticals, Inc. (AMLX)?
What is the 3-year average PE Ratio for Amylyx Pharmaceuticals, Inc. (AMLX)?
What is the 5-year average PE Ratio for Amylyx Pharmaceuticals, Inc. (AMLX)?
How does the current PE Ratio for Amylyx Pharmaceuticals, Inc. (AMLX) compare to its historical average?